Surgeon-Performed Touch Preparation of Breast Core Needle Biopsies May Provide Accurate Same-Day Diagnosis and Expedite Treatment Planning
Tóm tắt
Từ khóa
Tài liệu tham khảo
Devaraj S, Iqbal M, Donnelly J, Corder, AP. Axillary ultrasound in invasive breast cancer: experience of our surgeons. Breast J. 2011;17:191–195.
Law MT, Bennett IC. Structured ultrasonography workshop for breast surgeons: is it an effective training tool? World J Surg. 2010;34:549–554.
Layeequr Rahman R, Crawford S, Hall T, et al. Surgical-office-based versus radiology-referral-based breast ultrasonography: a comparison of efficiency, cost, and patient satisfaction. J Am Coll Surg. 2008;207:763–766.
Holmes DR, Silverstein MJ. A minimally invasive breast biopsy clinic: an innovative way to teach breast fellows how to perform breast ultrasound and ultrasound-guided breast procedures. Am J Surg. 2006;192:439–443.
Rakha EA, Ellis IO. An overview of assessment of prognostic and predictive factors in breast cancer needle core biopsy specimens. J Clin Pathol. 2007;60:1300–1306.
Willems SM, van Deurzen CH, van Diest PJ. Diagnosis of breast lesions: fine-needle aspiration cytology or core needle biopsy? A review. J Clin Pathol. 2012;65:287–292.
Garg S, Mohan H, Bal A, Attri AK, & Kochhar S, et al. A comparative analysis of core needle biopsy and fine-needle aspiration cytology in the evaluation of palpable and mammographically detected suspicious breast lesions. Diagn Cytopathol. 2007; 35:681–689.
Smith MJ, Heffron CC, Rothwell JR, Loftus BM, Jeffers M, & Geraghty JG, et al. Fine needle aspiration cytology in symptomatic breast lesions: still an important diagnostic modality? Breast J. 2012;18:103–110.
Maeda S, Hosone M, Katayama H, Isobe H, Yanagida Y, Egami K, et al. Rapid diagnosis at the outpatient clinic for breast tumors by fine needle aspiration cytology: the utility. Nihon Ika Daigaku Zasshi. 1998;65:416–420.
Dayal S, Murray J, Wilson K, Lannigan A, et al. Imprint cytology from core biopsies increases the sensitivity of fine needle aspiration (FNA) in breast cancer patients. Magy Seb. 2011;64:59–62.
Kass R, Henry-Tillman RS, Nurko J, Korourian S, Mancino AT, Colvert M, et al. Touch preparation of breast core needle specimens is a new method for same-day diagnosis. Am J Surg. 2003;186:737–741.
Galen RS, Gambino SR. Beyond normality: the predictive value and efficiency of medical diagnoses. New York: Wiley; 1975.
Dey P, Bundred N, Gibbs A, Hopwood P, Baildam A, Boggis C, et al. Costs and benefits of a one stop clinic compared with a dedicated breast clinic: randomised controlled trial. BMJ. 2002;324:507.
Kulkarni D, Irvine T, Reyes RJ. The use of core biopsy imprint cytology in the ‘one-stop’ breast clinic. Eur J Surg Oncol. 2009;35:1037–1040.
Carmichael AR, Berresford A, Sami A, Boparai R. Imprint cytology of needle core-biopsy specimens of breast lesion: is it best of both worlds? Breast. 2004;13:232–234.
Klevesath MB, Godwin RJ, Bannon R, Munthali L, & Coveney E. Touch imprint cytology of core needle biopsy specimens: a useful method for immediate reporting of symptomatic breast lesions. Eur J Surg Oncol. 2005;31:490–494.
Masood S, Feng D, Tutuncuoglu O, Fischer G, Bakhshandeh M, Bertholf RL, et al. Diagnostic value of imprint cytology during image-guided core biopsy in improving breast health care. Ann Clin Lab Sci. 2011;41:8–13.
Qureshi NA, Beresford A, Sami S, Boparai R, Gosh S, & Carmichael AR, et al. Imprint cytology of needle core-biopsy specimens of breast lesions: is it a useful adjunct to rapid assessment breast clinics? Breast. 2007;16:81–85.
Farshid G, Pieterse S. Core imprint cytology of screen-detected breast lesions is predictive of the histologic results. Cancer. 2006;108:150–156.
Jones L, Lott MF, Calder CJ, & Kutt E. Imprint cytology from ultrasound-guided core biopsies: accurate and immediate diagnosis in a one-stop breast clinic. Clin Radiol. 2004;59:903–908.
Dixon JM, Mansel RE. ABC of breast diseases: symptoms assessment and guidelines for referral. BMJ. 1994;309:722–726.
Eastman A, Tammaro Y, Moldrem A, Andrews V, Huth J, Euhus D, et al. Outcomes of delays in time to treatment in triple negative breast cancer. Ann Surg Oncol. 2013; 20: 1880–1885.
Mujar M, Dahlui M, Yip CH, & Taib NA, et al. Delays in time to primary treatment after a diagnosis of breast cancer: does it impact survival? Prev Med. 2013; 56: 222–224.
Brazda A, Estroff J, Euhus D, Huth J, Andrews V, Moldrem A, et al. Delays in time to treatment and survival impact in breast cancer. Ann Surg Oncol. 2010; 17(Suppl. 3): 291–296.